NSC |
Compound |
Enrichment |
Correlation |
NSC 716089 |
Null |
0.00479683626511385 |
0.32378793 |
NSC 205555 |
Butanoic acid, 2,3-dibromo-4-[(5-chloro-2-methoxyphenyl)amino]-4-oxo- |
0.00479683626511392 |
0.46902619 |
NSC 641233 |
2-Naphthalenebutanamide, N-(3-chloro-1,4-dihydro- 1,4-dioxo-2-naphthalenyl)-.beta.-(1,3-dihydro-3-oxo- 1-isoindolyl)-.alpha.-,-.gamma.-dioxo- |
0.00479683626511392 |
0.57329306 |
NSC 643813 |
3'-O-(Carboxymethyl)-(Z)-Combretastatin 4-A, Na salt, hydrate [1:1:2] |
0.00479683626511392 |
0.57768247 |
NSC 643859 |
Null |
0.00479683626511392 |
0.30725451 |
NSC 652809 |
Null |
0.00479683626511392 |
0.59927826 |
NSC 658798 |
Null |
0.00479683626511392 |
0.51181649 |
NSC 668814 |
1-Oxa-4,7,10,13,16-pentaazacyclononadecane, cyclic peptide derivative |
0.00479683626511392 |
-0.26342966 |
NSC 104801 |
Cytembena |
0.00645628049634952 |
0.43096277 |
NSC 132791 |
Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo |
0.00645628049634952 |
0.38994582 |